Press enter or spacebar to select a desired language.
Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3131 - 3140 of 3442 results found

The Use of Leucovorin in Colorectal Cancer

MeSH Terms

Levoleucovorin (D03.438.733.631.400.800.350.450.500); Fluorouracil (D03.383.742.698.875.404); Colorectal Neoplasms (C04.588.274.476.411.307); Leucovorin (D03.438.733.631.400.800.350.450)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2016

The use of statins in the primary prevention of cardiovascular disease: an online tool for shared-decision making

MeSH Terms

Cardiovascular Diseases; Decision Making, Computer-Assisted; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Primary prevention

Guideline Contact
Kristophe De Meester
Publication Date
23/01/2020
Publication Scope
Provide locally-adaptable, clear, science-informed, clinical practice recommendations on the management of patients with LMD in terms of revascularization modality: CABG or PCI.
Countries of Application
Belgium
Guideline Publication Status
Published
Languages
Dutch
English
French
Authors
KCE (BE)
Publication Year
2020

The use of systemic treatment in the maintenance of patients with non-small cell lung cancer

MeSH Terms

Meta-Analysis (V03.600); Randomized Controlled Trial (V03.200.700); Random Allocation (E05.318.780.700); Lung Neoplasms (C04.588.894.797.520)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2015
Buttons

The use of targeted therapies in patients with inoperable locally advanced or metastatic renal cell cancer

MeSH Terms

Meta-Analysis as Topic (E05.581.500.501); Meta-Analysis (V03.600); Randomized Controlled Trial (V03.200.700); Kidney Neoplasms (C04.588.945.947.535); Carcinoma; Renal Cell (C04.557.470.200.025.390); Angiogenesis Inhibitors (D27.505.696.377.077.099); Antineoplastic Agents (D27.505.954.248)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
treatment
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2017

The Utility of PET/CT in Breast Cancer (Stages II-IV): An Evidence Summary

MeSH Terms

Tomography; Emission-Computed (E01.370.350.350.800); Deoxyglucose (D09.254.229); Glucose (D09.546.359.448); Breast (A01.236)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
assessment
screening
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2014

The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary

MeSH Terms

Neoplasm Staging (E01.789.625); Colon (A03.556.124.526.356); Tomography; Emission-Computed (E01.370.350.350.800); Deoxyglucose (D09.254.229)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
assessment
screening
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2014

The Utility of Positron Emission Tomography in Epilepsy

MeSH Terms

Epilepsy (C10.228.140.490); Tomography; Emission-Computed (E01.370.350.350.800); Humans (B01.050.150.900.649.801.400.112.400.400)

Guideline Contact
Cindy Walker-Dilks (pebconc@mcmaster.ca)
Publication Scope
assessment
implementation
screening
Countries of Application
Canada
Guideline Publication Status
Published
Languages
English
Authors
McMaster University (CA)
Publication Year
2015

Therapeutic drug monitoring of biologics in inflammatory bowel disease: an evidence-based multidisciplinary guideline

MeSH Terms

Inflammatory bowel diseases;
Therapeutic drug monitoring;  
Biologics;

Guideline Contact
Yu Zhang, whxhzy@163.com
Keywords
Inflammatory bowel diseases; Therapeutic drug monitoring; Biologics; Evidence-based multidisciplinary guideline
Date for Review
01/10/2024
Expected Publication Date
01/01/2025
Date of Last Evidence Search
15/12/2023
Methods Applied
Systematic review; Evidence synthesis; GRADE assessment of quality of evidence; GRADE evidence to decision framework; GRADE adolopment;
Publication Scope
Individualized therapy in biologics of inflammatory bowel disease
Countries of Application
Asia-Pacific countries
Guideline Publication Status
Development
Languages
English
Authors
1. Chen Shi Department of Pharmacy, Union Hospital, Tongji Medicial College, Huazhong University of Science and Technology;Hubei Province Clinical Research Center for Precision Medicine for Critical Illness, Wuhan, China 2. Hong Zhou Department of Pha
Willingness to Collaborate
Yes
Name of Endorsing Organization
Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee, Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association, Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society, Chin
Buttons

Therapie akuter und chronischer immunvermittelter Neuropathien und Neuritiden. S2e-LL (DGN)

MeSH Terms

Autoimmune Diseases of the Nervous System (C10.114)

Guideline Contact
Ina Kopp (imwi@awmf.org)
English Title Translation
Therapy of acute and chronic immune-mediated neuropathy and neuritis
Date for Review
31/12/2024
Publication Scope
management
Countries of Application
Germany
Guideline Publication Status
Under Review
Languages
German
Authors
AWMF (DE)
Publication Year
2018
My Saved Lists